chronic obstructive pulmonary disease, diagnosis and treatment
Article Quality & Performance Metrics
Readership in this journal
PopularRanked #21 of 40 articles by views in scandinavian journal of immunology
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
Chronic obstructive pulmonary disease (COPD) is one of a group non communicable diseases that public health has been an issues in Indonesia. At the 2007 in United State, COPD is the third leading cause of death. Smoking habit is a major cause COPD. Symptoms and sign were generally nonspecific. The provision of therapy that late can provide the impact of death. Spyrometry needed for clinical diagnosis COPD. Comparison FEV1/FVC <0,70 after bronchodilator medication can diagnose COPD. Bronchodilator medication is a first line treatment for COPD. Any medicine must specific against each patient, because symptoms and severity of limitations air flow affected by many factors.
| Reference Key |
putra2013e-jurnalchronic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | |
| Journal | scandinavian journal of immunology |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
ZincirX productsfrom the team behind Journament
-
PatentYazar
Patent drafts for the EPO, USPTO and TürkPatent
From inventor notes to a DOCX draft: description, claims, abstract. The machine drafts, the attorney signs.
See how it works (opens in a new tab) -
Projenator
Have a project idea? Score and plan it with AI
AI scores your idea in five dimensions and builds a phased plan. Your first project is free, no card needed.
Start your first project (opens in a new tab)
Cookies
We use strictly necessary cookies to run the site and keep you signed in. With your permission we would also use Google Analytics to see how the site is used, and Google AdSense to show ads on journal and article pages. Both stay off unless you accept, and you can change your mind at any time. How we use cookies · KVKK notice (Türkiye)
Cookie settings
Comments
No comments yet. Be the first to comment on this article.